Publications

ExpHem Journal

New Article Types and Author Incentives for Publishing in ExpHem

Introducing New Article Types

The International Society for Experimental Hematology (ISEH) and our society-owned journal, Experimental Hematology (ExpHem), invite submissions to two exciting new article types designed to accelerate discovery and innovation in hematology research. These new submission formats provide a dedicated platform for publishing valuable research outputs that currently have no mechanism for publication in other journals.

Standards in Hematology

Our Standards in Hematology papers provide a dedicated platform for rigorously validated techniques, protocols, and experimental frameworks that enhance reproducibility, standards, and community resources across the field.

Looking for some inspiration? Explore this published article in ExpHem on a consensus approach for  multipotent progenitor identification for a glimpse of the types of scientific discussions and perspectives we hope to feature in our society's journal. 

ExpHem Insights

Our ExpHem Insights submission type showcases impactful findings that don't fit a traditional manuscript model. This article type welcomes:

  • Novel phenomenological observations with potential mechanisms
  • Robust cell phenotyping studies without requiring complete mechanistic resolution
  • Well-contextualized negative results and null hypothesis findings
  • High-value datasets and other impactful contributions

Submissions should clearly articulate limitations, outline next steps, and highlight how the work advances hematology, while also embracing contributions such as high-value datasets.

Review our Guide for Authors for more information

Fast-Track Submissions

Don't forget - ExpHem also offers fast-track review submissions! Receive an editorial decision within 710 days of submission through our expedited Fast-Track Submission option. This pathway is available for research articles that fall within the scope of Experimental Hematology and have previously been reviewed by another high-impact journal. To be considered for Fast-Track review, authors must provide the prior reviewers’ comments along with a detailed response addressing those comments.

Author Incentivization Program

To celebrate the launch of these new article types, we're excited to announce a new submission incentivization program!

The first 20 authors with an accepted manuscript* in ExpHem will be eligible to receive a $650 discount that can be applied toward ISEH Annual Scientific Meeting registration and/or a future ISEH membership.

Program Details, Eligibility, and Guidelines

  • Manuscript submissions must be received between 25 July and 31 December 2026. Manuscript must be accepted prior to 31 July 2027. 
  • Discount codes will remain valid for 12 months and can be applied toward a future ISEH Annual Scientific Meeting registration and/or a future ISEH membership.
  • Discount codes will be provided to the first 20 authors who have an accepted, eligible article in ExpHem. We will use submission date and article type to identify the first 20 eligible authors, pending that those articles are ultimately accepted for publication. Authors of non-accepted manuscripts are not eligible for this author incentive program.  
  • *Eligible article types include: the new Standards in Hematology and ExpHem Insights, as well as both Standard and Fast-track original research papers and Brief Communications.

For questions regarding the author incentivization program, please contact info@iseh.org

Want to discuss a potential manuscript submission? Contact a member of our ExpHem Editorial Team.

Editor-in-Chief: Toshio Suda, MD, PhD, sudato@keio.jp

Chief Associate Editor: Keisuke Ito, MD, PhD, keisuke.ito@einsteinmed.edu

Managing Editor: Katie Pegram, managingeditor_exphem@publishingsolutions.net

About the Journal

Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.
 

ISEH Active members receive a subscription to Experimental Hematology. If you forgot your login and password, please contact info@iseh.org

Exploring Experimental Hematology

ExpHem June 2026 Issue
ExpHem May 2026 Issue
New Review Highlights the Gene Regulatory Mechanisms Underlying Hematopoietic Development